Literature DB >> 25656853

Salivary gland FNA cytology: role as a triage tool and an approach to pitfalls in cytomorphology.

P Mairembam1, A Jay1, T Beale2, S Morley2, F Vaz3, N Kalavrezos3, G Kocjan1.   

Abstract

OBJECTIVE: To highlight the importance of salivary gland fine needle aspiration (FNA) cytology as a triage tool for surgery and to determine its sensitivity and specificity. To discuss the diagnostic pitfalls and potential role of ancillary techniques in diagnosis and prognosis.
METHODS: The study included a total of 920 cases of salivary gland FNAs received in the cytopathology department of University College London Hospital during December 2004 to December 2012. The cases with known histological outcomes were analysed to determine the sensitivity and specificity.
RESULTS: Surgery was carried out on 180 (19.6%) of 920 patients. Excluding nine with inadequate/non-diagnostic cytology, the sensitivity of FNA cytology for a malignant outcome was 89% (33/37) and the specificity was 97% (130/134). Diagnostic pitfalls are discussed with respect to eight FNAs with discrepant histology. Histological outcome was not available for 740 cases (80.4%): excluding 88 non-diagnostic FNAs, 324 (49.7%) had non-neoplastic diagnoses (not indicating surgery) and 328 (50.3%) had neoplastic diagnoses, which included recurrences/metastases of known tumours. Patients with other neoplasms on FNA were lost to follow-up and may have had surgery elsewhere. Cases with clinical concerns were discussed at weekly multidisciplinary meetings.
CONCLUSION: Salivary gland FNA is crucial in the distinction of non-neoplastic from neoplastic lesions, emphasizing the fact that FNA is an excellent triage tool for surgery. Salivary gland FNA has a high sensitivity and specificity. However, it is important to interpret the cytological diagnoses in the light of clinical findings and imaging. Diagnostic pitfalls are seen in a minority of cases and could potentially be overcome with the help of recently described diagnostic and prognostic markers.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  accuracy; cytology; diagnostic pitfalls; fine needle aspiration; neoplasms; salivary gland

Mesh:

Year:  2015        PMID: 25656853     DOI: 10.1111/cyt.12232

Source DB:  PubMed          Journal:  Cytopathology        ISSN: 0956-5507            Impact factor:   2.073


  7 in total

1.  Knockdown of lncRNA ENST00000603829 Inhibits the Proliferation and Invasion of Salivary Gland Pleomorphic Adenoma through Regulating Cyclin D1.

Authors:  Yi Xu; Xin Sun; Jing Chen; Jinbiao Xu; Junshui Wei
Journal:  Appl Bionics Biomech       Date:  2022-04-27       Impact factor: 1.664

2.  Milan System for Reporting Salivary Gland Cytopathology- An Experience from Western Indian Population.

Authors:  Vaishali P Gaikwad; Chanda Anupriya; Leena P Naik
Journal:  J Cytol       Date:  2020-04-02       Impact factor: 1.000

3.  Risk-based Stratification of Salivary Gland Lesions on Cytology: An Institutional Experience.

Authors:  Pooja Jaiswal; Mousumi Sharma; Faraz Ahmad; Nausheen Sanaullah Khan; Sinha Siddhartha Shanker; Megha Agarwal
Journal:  Iran J Pathol       Date:  2018-07-17

4.  Milan System for Reporting Salivary Gland Cytopathology: An Experience with the Implication for Risk of Malignancy.

Authors:  Chayanika Kala; Sanjay Kala; Lubna Khan
Journal:  J Cytol       Date:  2019 Jul-Sep       Impact factor: 1.000

5.  The risk for malignancy using the Milan salivary gland classification categories: A 5-year retrospective review.

Authors:  Christine A Liang; Jing Liu; Jaiyeola Thomas Ogunniyi; Hui Zhu; Songlin Zhang
Journal:  Cytojournal       Date:  2019-07-25       Impact factor: 2.091

6.  A microRNA signature for the differential diagnosis of salivary gland tumors.

Authors:  Maria Denaro; Elena Navari; Clara Ugolini; Veronica Seccia; Valentina Donati; Augusto Pietro Casani; Fulvio Basolo
Journal:  PLoS One       Date:  2019-01-25       Impact factor: 3.240

7.  The Milan System for Reporting Salivary Gland Cytopathology: An outcome of retrospective application to three years' cytology data of a tertiary care hospital.

Authors:  Garima Singh; Aarzoo Jahan; Shakti Kumar Yadav; Ruchika Gupta; Namrata Sarin; Sompal Singh
Journal:  Cytojournal       Date:  2021-05-06       Impact factor: 2.091

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.